Search

You are hereBiblio

Biblio

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 
T
Regulating the products of nanotechnology : Does the FDA have the Tools it Needs?, Taylor, Michael , October, 2006, p.61 p., (2006) Abstract
Nanotech-enabled Consumer Products Continue to Rise : Oversight Challenges Still Exist , , 10/03/2011, Number 11/03/2011, Washington, D.C., (2011) Abstract
Poll reveals public awareness of nanotech stuck at low level: American look to government to ensure safety of new technology, , 09/2007, Number 11 August 2010, Washington, D.C., (2007) Abstract
M
Federal research plan to determine nanotech risks fails to deliver, McCarter, Sharon , Woodrow Wilson International Center for Scholars News Release , 09/13/2007, (2007) Abstract
Consumers talk nano, , Consumers Talk Nano (23-24 October 2007, Online Discussion), 10/24/2007, (2007) Abstract
W
The social and economic challenges of nanotechnology, Wood, Stephen, Jones Richard, and Geldart Alison , Swindon, UK, p.63 p., (2003) Abstract
Nanotechnology : from the science to the social, Wood, Stephen, Jones Richard, and Geldart Alison , p.51 p., (2007) Abstract
Crystallizing the nanotechnology debate, Wood, Stephen, Geldart Alison, and Jones Richard , Technology Analysis and Strategic Management, January 2008, Volume 20, Issue 1, p.13-27, (2008) Abstract
Nanoregulation: A recent scare involving nanotech products reveals that the technology is not yet properly regulated , Wolinsky, Howard , EMBO Reports , Volume 7, Issue 9, p.858-861, (2006) Abstract
Social and ethical issues in nanotechnology : Lessons from biotechnology and other high technologies, Wolfson, Joel Rothstein , Biotechnology Law Report, August, 2003, Volume 22, Issue 4, p.376-396, (2003) Abstract
Gene Therapy Oversight: Lessons for Nanobiotechnology, Wolf, Susan M., Gupta Rishi, and Kohlhepp Peter , Journal of Law, Medicine & Ethics, Winter2009, Volume 37, Issue 4, p.659-684, (2009) Abstract

Wolf, Susan M. 1 Gupta, Rishi 2 Kohlhepp, Peter 3; Affiliation: 1: McKnight Presidential Professor of Law, Medicine & Public Policy; Faegre & Benson Professor of Law; Professor of Medicine; and Faculty Member in the Center for Bioethics at the University of Minnesota. 2: Holds an M.S. in Applied Physics from the University of Texas at Dallas and a J.D. from the University of Minnesota Law School. He is currently an Associate at Fish and Richardson PC. in Dallas, Texas. 3: Received his J.D. from the University of Minnesota Law School in May 2009. He is currently an Associate at Carlson, Caspers, Vandenburgh and Lindquist in Minneapolis.; Source Info: Winter2009, Vol. 37 Issue 4, p659; Subject Term: GENE therapy; Subject Term: BIOTECHNOLOGY; Subject Term: NANOTECHNOLOGY; Subject Term: TECHNOLOGICAL innovations; Subject Term: GENETIC transformation; Subject Term: RESEARCH; Subject Term: MEDICINE -- Research; NAICS/Industry Codes: 541712 Reseach and Development in the Physical, Engineering, and Life Sciences (except Biotechnology); Number of Pages: 26p; Illustrations: 3 Charts; Document Type: Article

Why NBIC? Why human performance enhancement?, Wolbring, Gregor , Innovation: The European Journal of Social Sciences, March 2008, Volume 21, Issue 1, p.25-40, (2008) Abstract
Solutions follow perceptions: NBIC and the concept of health, medicine, disability and disease., Wolbring, G. , Health Law Review, Fall, 2004, Volume 12, Issue 3, p.41-46, (2004) Abstract
The Choice is Yours: NBICS and Military Products, Wolbring, Gregor , January 30, 2007, (2007) Abstract
The ruse and reality of nanotechnology, Woklaw, Robert A. , Health Law Review, Fall, 2004, Volume 12, Issue 3, p.14-19, (2004) Abstract
A nanotechnology policy framework for California : Policy recommendations for addressing potential health risks from nanomaterials, Wise, Amber R., Schwartz Jackie, and Woodruff, Tracy J. , San Francisco, p.76 p., (2010) Abstract
Societal Implications of Nanotechnology : Testimony to the Committee on Science of the U.S. House of Representatives, Winner, Langdon, and Winner Langdon , April 9, 2003, (2003) Abstract
UK researcher's findings raise flags about nanotechnology use , Wilson, Amy , Lexington Herald-Leader , 7 March 2011, Lexington , (2011) Abstract
The politics of small things: nanotechnology, risk, and uncertainty, Wilsdon, J. , IEEE Technology and Society Magazine, 24/2004, Volume 23, Issue 4, p.16 - 21, (2004) Abstract
See through science: why public engagement needs to move upstream, Wilsdon, James, and Willis Rebecca , 09/2004, p.71 p., (2004) Abstract
Compressed foresight and narrative bias : Pitfalls in assessing high technology futures, Williams, Robin , Science as Culture, December , 2006, Volume 15, Issue 4, p.327-348, (2006) Abstract
From uncertainty to risk? : scientific and news media portrayals of nanoparticle safety, Wilkinson, Clare, Allan Stuart, Anderson Alison, and Peterson Alan , Health, Risk and Society, June, 2007, Volume 9, Issue 2, p.145-157, (2007) Abstract
Nanotechnology: new technology but old business models?, Wilkinson, J. M. , Nanotechnology Perceptions: a Review of Ultraprecision Engineering , Volume 2, Issue 3, p.277-282, (2006) Abstract
Nanosilver: a test for nanotech regulation., Wilhelmi, Brian , Food and drug law journal, 2008, Volume 63, Issue 1, p.89-112, (2008) Abstract
Exposure to nanomaterials in consumer products, Wijnoven, S. W. P., Dekkers S., Hagens W. I., and de Jong W. H. , 2009, Bilthoven, the Netherlands, p.47 p., (2009) Abstract

Navigation

Further Resources